Skip to main content

Table 3 Univariate analysis for prognostic factors of viral-HCC vs. viral marker negative HCC

From: Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma

Variables

OR(95% CI)

P value

Variables

OR(95% CI)

P value

Age(years)

1.026(1.01-1.05)

0.01

Hepatopulmonary Syndrome

 

Gender

 

No

1.0

0.19

  Female

1.0

0.34

Yes

1.62(0.80-3.29)

 

  Male

1.26(0.77-2.05)

 

Total Bilirubin(mg/dl)

 

BMI (Kg/m2)

 

<2

1.0

0.48

  18-22.9

1.0

0.24

2-3

0.93(0.51-1.67)

 

  <18

2.08(0.90-4.77)

 

>3

1.29(0.79-2.09)

 

  23-24.9

1.34(0.74-2.43)

 

Albumin(mg/dl)

 

  ≥25

0.98(0.56-1.69)

 

>3.5

1.0

0.73

Diabetes Mellitus

 

2.8-3.5

0.73(0.32-1.62)

 

  No

1.0

0.02

<2.8

0.74(0.35-1.56)

 

  Yes

1.64(1.07-2.53)

 

ALT (IU/ml)

 

Hypertension

 

Normal

1.0

0.19

  No

1.0

0.11

Elevated

0.58(0.37-0.91)

 

  Yes

1.42(0.92-2.21)

 

Prothrombin time(second)

 

Dyslipidemia

 

<3

1.0

0.14

  No

1.0

0.74

3-6

0.61(0.3-1.02)

 

  Yes

0.74(0.17-3.50)

 

>6

0.91(0.53-1.55)

 

Child score

1.02(0.93-1.12)

0.59

Platelets counts (10 9 /L)

1.01(1.0-1.01)

<0.001

Child class

 

AFP(IU/ml)

 

  A

1.0

0.50

≤200

1.0

0.53

  B

1.02(0.50-2.11)

 

>200

0.86(0.56-1.34)

 

  C

1.32(0.65-2.67)

 

Duration between diagnosis of cirrhosis

 

Okuda class

 

00

2.90(1.43-5.88)

<0.001

  I

1.0

0.97

1-55

1.10(0.51-2.40)

 

  II

0.99(0.52-1.87)

 

>55

1.0

 

  III

1.15(0.51-2.15)

 

Mode of diagnosis

 

Complication of CLD

 

On screening

1.0

0.001

  No

1.0

0.39

Incidental

15.36(1.93-122.14)

 

  Yes

1.24(0.74-2.07)

 

Symptomatic

9.82(1.34-72.01)

 

Hyperspleenism

 

Stage of HCC

 

  No

1.0

0.14

Non-Advance

1.0

<0.001

  Yes

0.72(0.46-1.11)

 

Advance

3.08(1.79-5.28)

 

Ascites

 

Macroscopic types of HCC

 

  No

1.0

0.84

Solitary

1.0

0.04

  Yes

0.95(0.60-1.51)

 

Paucifocal (≤ 3 nodules)

1.04(0.62-1.73)

 

PSE

 

Multifocal(>3 nodules)

1.38(0.73-2.63)

 

  No

1.0

0.23

Massive/infiltrative

2.7(1.28-5.69)

 

  Yes

1.31(0.84-2.03)

 

Maximum tumor size(cm)

 

Esophageal Varices

 

< 5

1.0

<0.001

  No

1.0

 

5-10

2.08(1.39-3.75)

 

  Yes

0.84(0.55-1.29)

0.44

>10

5.46(3.01-9.93)

 

Upper GI bleed

 

Hepatic Lobes

 

  No

1.0

 

Left

1.0

0.98

  Yes

0.90(0.58-1.40)

0.64

Right

1.05(0.53-2.06)

 

Hepatohydrothorax

 

Both

1.03(0.49-2.16)

 

  No

1.0

0.43

Porto Venous Thrombosis

 

  Yes

1.32(0.66-2.65)

 

No

1.0

0.33

Hepatorenal Syndrome

 

Yes

1.25(0.788-2.00)

 

Extra hepatic spread

 

  No

1.0

0.50

No

1.0

0.12

  Yes

1.18(0.72-1.94)

 

Yes

1.58(0.89-2.81)

Â